Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-15-049665

← back to feed
Filed
Aug 14, 2015 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Aug 14, 2015 22.01M sh
Short Term Debt Q2 2015 · Jun 30, 2015 $190K
Short Term Debt Q2 2015 · Dec 31, 2014 $200K
Cash And Equivalents Q2 2015 · Jun 30, 2015 $28.07K
Cash And Equivalents Q2 2015 · Dec 31, 2014 $12.51K
Cash And Equivalents Q2 2015 · Jun 30, 2014 $55.93K
Cash And Equivalents Q2 2015 · Dec 31, 2013 $44.9K
Stockholders Equity Q2 2015 · Jun 30, 2015 −$7.04M
Stockholders Equity Q2 2015 · Dec 31, 2014 −$5.66M
Current Liabilities Q2 2015 · Jun 30, 2015 $6.36M
Current Liabilities Q2 2015 · Dec 31, 2014 $4.98M
Total Liabilities Q2 2015 · Jun 30, 2015 $7.06M
Total Liabilities Q2 2015 · Dec 31, 2014 $5.68M
Current Assets Q2 2015 · Jun 30, 2015 $28.07K
Current Assets Q2 2015 · Dec 31, 2014 $12.51K
Total Assets Q2 2015 · Jun 30, 2015 $28.07K
Total Assets Q2 2015 · Dec 31, 2014 $12.51K
Sga Expense Q2 2015 · Jun 30, 2015 $927.16K
Sga Expense Q2 2015 · Jun 30, 2015 $1.04M
Sga Expense Q2 2015 · Jun 30, 2014 $162.71K
Sga Expense Q2 2015 · Jun 30, 2014 $257.78K
Rd Expense Q2 2015 · Jun 30, 2015 $161.07K
Rd Expense Q2 2015 · Jun 30, 2015 $321.98K
Rd Expense Q2 2015 · Jun 30, 2014 $125.03K
Rd Expense Q2 2015 · Jun 30, 2014 $275.3K
Net Income Q2 2015 · Jun 30, 2015 −$1.1M
Net Income Q2 2015 · Jun 30, 2015 −$1.37M
Net Income Q2 2015 · Jun 30, 2014 −$892.93K
Net Income Q2 2015 · Jun 30, 2014 −$1.2M
Operating Income Q2 2015 · Jun 30, 2015 −$1.09M
Operating Income Q2 2015 · Jun 30, 2015 −$1.36M
Operating Income Q2 2015 · Jun 30, 2014 −$287.74K
Operating Income Q2 2015 · Jun 30, 2014 −$533.09K
Revenue Q2 2015 · Jun 30, 2015 $0
Revenue Q2 2015 · Jun 30, 2015 $0
Revenue Q2 2015 · Jun 30, 2014 $0
Revenue Q2 2015 · Jun 30, 2014 $0